New House bill addresses ‘drug lag’ – helping drugs OK’d in Europe reach U.S. patients
The FDA might speed up the review process for drugs that have already received marketing approval in Europe, if a new bill introduced in the House of Representatives goes through. Called the “Speeding Access to Already Approved Pharmaceuticals Act,” the bipartisan bill was actually first introduced last June. The bill addresses the issue of “drug lag” – […]